Ampio Pharmaceuticals
AMPE
#10582
Rank
HK$2.28 M
Marketcap
HK$2.02
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -HK$133.71

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$133.13. In 2022 the company made an earnings per share (EPS) of -HK$169.38 an increase over its 2021 EPS that were of -HK$210.94.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$133.71-21.06%
2022-HK$169.38-19.7%
2021-HK$210.94-0%
2020-HK$210.94-10%
2019-HK$234.38-121.74%
2018HK$1,078-158.23%
2017-HK$1,852119.44%
2016-HK$843.77-41.94%
2015-HK$1,453-18.42%
2014-HK$1,78120.63%
2013-HK$1,47785.29%
2012-HK$796.90-52.11%
2011-HK$1,66444.9%
2010-HK$1,148390%
2009-HK$234.38233.33%
2008-HK$70.31-0%
2007-HK$70.31
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.44-110.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.95-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$339.38-354.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
HK$49.45-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.86-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA